tiprankstipranks
Trending News
More News >
Diaceutics (GB:DXRX)
LSE:DXRX
UK Market
Advertisement

Diaceutics (DXRX) Technical Analysis

Compare
10 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
4Neutral
2Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Diaceutics’s (DXRX) Moving Averages Convergence Divergence (MACD) indicator is 2.35, suggesting Diaceutics is a Buy.
Diaceutics’s (DXRX) 20-Day exponential moving average is 136.70, while Diaceutics’s (DXRX) share price is 140p, making it a Buy.
Diaceutics’s (DXRX) 50-Day exponential moving average is 132.33, while Diaceutics’s (DXRX) share price is 140p, making it a Buy.

Diaceutics (DXRX) Pivot Points

Sep 04, 2025, 11:42 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
130.67
133.33
136.67
139.33
142.67
145.33
148.67
Fibonacci
133.33
135.63
137.04
139.33
141.63
143.04
145.33
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Diaceutics (DXRX) Moving Averages

Sep 04, 2025, 11:42 AM
Period
Simple
Exponential
MA5
138.50Buy
138.89Buy
MA10
138.00Buy
138.22Buy
MA20
137.75Buy
136.70Buy
MA50
128.83Buy
132.33Buy
MA100
126.89Buy
129.74Buy
MA200
128.76Buy
129.09Buy
Diaceutics’s (DXRX) 10-Day exponential moving average is 138.22, while Diaceutics’s (DXRX) share price is 140p, making it a Buy.
Diaceutics’s (DXRX) 100-Day exponential moving average is 129.74, while Diaceutics’s (DXRX) share price is 140p, making it a Buy.
Diaceutics’s (DXRX) stock price is 140p and Diaceutics’s (DXRX) 50-day simple moving average is 128.83, creating a Buy signal.
Diaceutics’s (DXRX) stock price is 140p and Diaceutics’s (DXRX) 100-day simple moving average is 126.89, creating a Buy signal.
Diaceutics’s (DXRX) stock price is 140p and Diaceutics’s (DXRX) 200-day simple moving average is 128.76, creating a Buy signal.

Diaceutics (DXRX) Technical Indicators

Sep 04, 2025, 11:42 AM
Name
Value
Implied Action
RSI (14)
79.35
Sell
STOCH (9,6)
64.29
Neutral
STOCHRSI (14)
64.29
Neutral
MACD (12,26)
2.35
Buy
ADX (14)
43.00
Neutral
Williams %R
-28.57
Buy
CCI (14)
347.48
Sell
ATR (14)
4.26
-
Ultimate Oscillator
50.46
Neutral
ROC
1.82
Buy
Diaceutics’s (DXRX) Relative Strength Index (RSI) is 79.35, creating a Sell signal.
Diaceutics’s (DXRX) Trend Strength Indicator (ADX) is 43.00, creating a Neutral signal.
Diaceutics’s (DXRX) Commodity Channel Index (CCI) is 347.48, creating a Sell signal.
Diaceutics’s (DXRX) Price Rate of Change (ROC) is 1.82, creating a Buy signal.

FAQ

Is DXRX a Buy, Hold, or Sell?
Based on DXRX’s technical indicators, DXRX is a Strong Buy.
    What is DXRX’s RSI (14)?
    DXRX’s RSI (14) is 79.35, which suggests DXRX is a Sell.
      What is DXRX’s MACD?
      DXRX’s MACD is 2.35, which suggests DXRX is a Buy.
        What is DXRX’s 5-day moving average?
        DXRX’s 5-day moving average is 138.50, which suggests DXRX is a Buy.
          What is DXRX’s 20-day moving average?
          DXRX 20-day moving average is 137.75, which suggests DXRX is a Buy.
            What is DXRX’s 50-day moving average?
            DXRX’s 50-day moving average is 128.83, which suggests DXRX is a Buy.
              What is DXRX’s 200-day moving average?
              DXRX’s 200-day moving average is 128.76, which suggests DXRX is a Buy.
                What is DXRX’s Williams % R (14)?
                DXRX’s Williams % R (14) is -28.57, which suggests DXRX is a Buy.
                  What is DXRX’s CCI (14)?
                  DXRX’s CCI (14) is 347.48, which suggests DXRX is a Sell.
                    What is the share price of Diaceutics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis